The courts are considering ending telemedicine access to mifepristone, one of the two pills used in a medication abortion. Here's what's happened this week and what's to come.

One drug is at the center of the current legal battle over abortion: mifepristone.Since the Supreme Court overturned Roe v. Wade in 2022, mifepristone has become the dominant method of abortion in the United States,

At a press conference Tuesday morning, Gov. Ned Lamont reminded Connecticut residents of state resources available to access information in the wake of federal uncertainty.

In 2023, the Food and Drug Administration started allowing mifepristone to be delivered by mail. The federal courts are deciding whether to pull that permission.

Starting next Monday, doctors may not be able to mail people the abortion pill Mifepristone. That would increase barriers, but experts say it won't stop people's ability to get the pills in the mail.

A federal appeals court ruling restricting access to the abortion pill mifepristone is raising concerns about how patients, including those in California, will obtain the medication moving forward.